NCT00229502View on ClinicalTrials.gov

Cognitive Effects of Immunomodulatory Drugs in MS

CompletedOBSERVATIONAL
Enrollment

96

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2011

Study Completion Date

December 31, 2011

Conditions
Multiple Sclerosis
Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

Sponsors

Collaborators (1)

EMD Serono
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

lead

Sharon Lynch, MD

OTHER

NCT00229502 - Cognitive Effects of Immunomodulatory Drugs in MS | Biotech Hunter | Biotech Hunter